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A B S T R A C T
Flow cytometric methods for detecting and quantifying reduced intracellular thiol content using
ﬂuorescein-5-maleimide (F5M) in viable eukaryotic cells date back to 1983 (Durand and Olive [1]). There
has been little development in these methodologies since that time, a period that has witnessed huge
technological advances, particularly with the emergence of digital multi-parameter ﬂow cytometric systems.
Concurrent advancement in our understanding of redox regulation within eukaryotic cellular systems has also
followed, whereby it is now accepted that cysteine thiols partake in redox reactions, which regulate protein
activity and function (Groitl and Jakob (2014), Won et al. (2012)). Moreover, we are at the dawn of a new era
in redox biology whereby the importance of ‘reductive stress’ in eukaryotic cellular systems is gathering
momentum (Wadley et al. (2018) [4]). It is therefore critical that methods be continually advanced to better
understand these concepts in more detail at the cellular level. Flow cytometry is a powerful technique that
may be used for this purpose. Henceforth we have rejuvenated these methods to address modern scientiﬁc
questions. In this paper, essential detail is provided on:
 The adaption of a protocol initially described by Durand and Olive [1] for use with modern digital ﬂow
cytometer conﬁgurations. Here we provide optimal conditions for labelling intracellular thiols with F5M for
detection using digital ﬂow cytometers. Our modiﬁcations avoid the use of methanol ﬁxation thus preserving
cell viability in single cell suspension cultures.
* Corresponding author at: School of Science and the Environment, University of Worcester, St John’s Campus, Henwick
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1 Demonstration that ﬂow cytometry can detect the gain and loss of reduced intracellular thiols
in cells exposed to physiological doses of hydrogen peroxide mediated by glucose oxidase (Hole et al. (2013)
[5]).
 Validation of F5M protein labelling by coupling method to confocal microscopy and downstream proteomics,
thus permitting a powerful experimental platform for potential use with next generation ﬂow cytometry e.g.
CyTOF (Lin and Maecker (2018) [6]).
 2018 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).
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Speciﬁcation Table
Subject area  Biochemistry, Genetics and Molecular Biology
More speciﬁc subject area Redox Biology, Cysteine Thiol Chemistry, Flow Cytometry and Mass Spectrometry
Method name Original customized method name: Flow cytometry techniques for studying cellular thiols.
Name and reference of
original method
If applicable, include full bibliographic details of the main reference(s) describing the original
method from which the new method was derived. See the following citation [1]
Resource availability n/a
ethods details
aterials
1 Complete IMDM tissue culture medium: containing 10% (v/v) foetal calf serum (FCS), 2 mM L-glutamine,
100 U/ml penicillin and 100 mg/ml streptomycin (Sigma-Aldrich, Dorset, UK).
2 Hank’s balanced salt solution (Sigma-Aldrich, Dorset, UK; catalogue #H9269).
3 Dulbecco’s phosphate buffered saline (D-PBS) endotoxin tested, pH 7.0 (Sigma-Aldrich, Dorset, UK;
catalogue #D8537).
4 Flow cytometry stain buffer (FSB): D-PBS adjusted to contain 2% (v/v) FCS, 0.1% (w/v) sodium azide
and 5 mM EDTA (stored at 4 C).
5 Ficoll-Paque PLUS (GE, Buckinghamshire, UK; catalogue #17144003) or Hisopaque 1077 (Sigma-
Aldrich, Dorset, UK; catalogue #10771).
6 Trypan blue solution 0.4% (Sigma-Aldrich, Dorset, UK; catalogue #T8154).
7 Glucose oxidase from Aspergillus niger (Sigma-Aldrich, Dorset, UK; catalogue #G2133): 100,000 U/g.
8 N-ethylmaleimide (NEM): 1 mM stock in D-PBS stored at 4 C protected from light (Sigma-Aldrich,
Dorset, UK; catalogue #E3876).
9 Fluorescein-5 maleimide (F5M): 1 mM stock in D-PBS stored at 4 C protected from light
(ThermoFisher, Hampshire, UK; catalogue #62245).
0 Anti-human CD3-APC, clone SK7 (BioLegend, London, UK; catalogue #344812).
11 Multi-parameter digital ﬂow cytometer.
Note: in our laboratory we use an Accuri-C6 (BD-Accuri, Berkshire, UK); however, the
method is compatible with other digital systems e.g. Guava1 EasyCyte (MerkMillipore,
Hertfordshire, UK)
2 NuPAGE 4–12% SDS-PAGE gel, MOPS running buffer and SDS-PAGE LDS sample loading buffer
(ThermoFisher, Hampshire, UK)
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Cells
1 Jurkat (ATCC1TIB-152
TM
), human acute T-cell lymphoblastic leukaemia.
2 Donor human peripheral blood mononuclear cells (PBMCs).
Note: full ethical approval and donor consent is required for the isolation of PBMCs from human
blood, in strict accordance with the declaration of Helsinki [7].
Experimental procedures
Analysing the effect of glucose oxidase mediated H2O2 on intracellular thiol oxidation using ﬂow cytometry
The protocol described is based on a previous method described in Durand and Olive [1], which
incorporated various ﬂuorescent stains for the detection of reduced intracellular thiols, including
ﬂuorescein-5 maleimide (F5M). The current method is optimised for bench-top digital ﬂow
cytometers and allows low level detection of F5M in viable cells, which proved challenging using the
previous method. The optimisation of the technique described herein is of particular importance,
since some reactive oxygen species (ROS) e.g. hydrogen peroxide (H2O2) have the propensity to oxidise
proteins with exposed cysteine residues, in turn altering their activity [8]. In the experimental model
proposed, exposure of cells to physiological doses of exogenous H2O2 can be modelled in vitro by
adding glucose oxidase (GOX) to the culture medium as previously described [5]. The addition of GOX
in this way will metabolise glucose in the culture medium, generating H2O2 as deﬁned by the
following reaction [9]:
β-D-glucose + oxygen → D-glucono-1,5,-lactone + hydrogen peroxide
Hydrogen peroxide is membrane permeable and can enter the cell mediating the oxidation of
intracellular cysteine residues [10]. To demonstrate this, the example included uses the Jurkat
immortalised T-cell line to monitor cellular cysteine thiol redox state over time in response to GOX
generated H2O2. The method details are as follows:
1 Maintain Jurkat cells in 15 ml complete IMDM, at a density between 2  105 and 106 cells/ml at
37 C and 5% CO2.
Note: IMDM is particularly suited to this because of the high glucose concentration (4.5 g/l), which
is a substrate for GOX.
2 Prepare a 10 mU/ml GOX solution and a 10 mg/ml catalase solution and store at 4 C until required.
Note: The catalase is used to conﬁrm that H2O2 is mediating changes in thiol redox state. To
prepare glucose oxidase solutions for in vitro H2O2 generation, it is recommended to obtain high
purity glucose oxidase solid (e.g. Sigma cat no. 49180 or similar quality). Cheaper preparations can
contain confounding contaminants such as catalase, which metabolises H2O2. In a Class
2 biological safety cabinet, dissolve solid GOX in tissue culture-grade water to a concentration
of 1 U/ml (U = enzyme units). Sterilise by ﬁltration and aliquot for storage at 20 C and avoid
freeze thaw. Prepare 10 mU/ml working solutions by thawing 1 U/ml stock aliquots at 37 C for
1 min and diluting with tissue culture-grade water immediately prior to use. Discard excess. Note
that H2O2 production generated by GOX in vitro can be measured and titrated to physiological
levels using the H2O2-speciﬁc ﬂuorescent probe Amplex UltraRed (Life Technologies, Hampshire,
UK) [5].
3 Transfer the contents of a 24–48 h Jurkat cell culture ﬂask (60–80% conﬂuence) to a 15 ml tube and
centrifuge at 100–300  g for 10 min at room temperature in a bench-top centrifuge with swing-
out rotor.
Note: Jurkat cells are non-adherent and do not require Trypsin-EDTA treatment to dislodge from
the ﬂask surface.
4 Remove the supernatant and carefully suspend the pellet in 1 ml complete IMDM pre-warmed to 37 C.
5 Perform a viable cell count using trypan blue and dilute the Jurkat cells to a viable density of 107
cells/ml.
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16 Add 100 ml of the diluted Jurkat cell suspension to ﬁve wells in a 96-well tissue culture treated
plate and label ‘0 h’, ‘1 h’, ‘2 h’, ‘3 h’, ‘4 h’.
7 Add 98 ml to two wells in the same plate and label; ‘0 h +C’ and ‘4 h +C’. Note the “+C” refers to the
addition of catalase. Thus there are 7 assay wells in total.
8 Add 2 ml of the 10 mg/ml catalase stock solution (prepared in step 2) to wells labelled ‘0 h +C’ and
‘4 h +C’ only.
9 To start the assay add 100 ml of the GOX solution (prepared in step 2) to wells labelled ‘4 h’ and ‘4 h
+C’ and incubate at 37 C and 5% CO2.
Note: that this assay has been optimised to use IMDM because of the high glucose content (4.5 g/l),
rather than RPMI-1640 which has much lower glucose content (2 g/l). This is important since GOX
requires a glucose substrate to generate H2O2.
10 After 1 h, add 100 ml of the GOX solution to the ‘3 h’ well and return to the incubator.
11 Repeat after a further 1 and 2 h for wells labelled ‘2 h’ and ‘1 h’ respectively.
12 Finally, 1 h after the addition of GOX to ‘1 h’, add 100 ml of the GOX solution to wells labelled ‘0 h’
and ‘0 h + C’ and immediately transfer the contents of all 7 assay wells to a fresh 1.5 ml
microcentrifuge tube. Centrifuge all at 100–300  g for 5 min at room temperature.
13 Carefully remove supernatants and suspend the pellets in 1 ml D-PBS. Centrifuge all tubes at 100–
300  g for 5 min at room temperature.
14 Remove supernatants and suspend pellets in 1 ml pre-chilled 0.1 mM F5M solution and incubate all
tubes for 20 min, on ice and protected from light.
15 Centrifuge tubes at 100–300  g for 5 min at 4 C.
16 Remove supernatants and suspend pellets in 1 ml pre-chilled FSB and centrifuge at 100–300  g for
5 min at 4 C.
17 Remove supernatants and suspend pellets in 100 ml FSB and go to ﬂow cytometer. Keep tubes on
ice and protect from light.
18 At the ﬂow cytometer, acquire the ‘0 h’ tube ﬁrst, followed by the others in chronological order.
Draw a region around the Jurkat cell population as seen in Fig. 1A and create an FL1 (l488 nm;
l530/30 nm) histogram gated on the region as seen in Fig.1B. Non-viable cells <8% can be excluded
from the ﬂow cytometric analysis by the addition of a cell viability stain e.g. 7AAD.
19 Normalise the FL1 mean ﬂuorescent intensity (MFI) values to ‘0 h’ in order interpret the ﬂow
cytometry data as shown in Fig. 1C and in Table 1.
Note: normalisation is performed by dividing the F5M signal by the F5M signal of non-GOX treated
controls i.e. 0 h.
0 To conﬁrm that GOX treatment is not inducing cell death, viable cell counts should be performed
on GOX treated cells before or after ﬂow cytometry acquisition as shown in Fig. 2A.
21 To demonstrate that the GOX generated H2O2 is mediating the loss in reduced thiols, the effect of
catalase in ‘4 h’ vs ‘4 h + C’ treated cells can be observed on normalised data as shown in Fig. 2B. The
data suggest that H2O2 mediates the loss in reduced intracellular thiols as measured by a loss in
F5M (FL1) ﬂuorescent signal.
ethod versatility and confocal microscopy conﬁrmation that the F5M signal is intracellular
To illustrate the versatility of our ﬂow cytometric method, we provide a protocol for evaluating
ntracellular thiol oxidation in heterogeneous cell populations i.e. T-cells within a peripheral blood
ononuclearcell (PBMC) fraction. Herewe couple the cell surface stainingof CD3 (T-cell marker) with F5M.
onfocal microscopy was used to verify that F5M signal detected by ﬂow cytometry was intracellular and
ot due to F5M binding at the plasma membrane. Venous blood from healthy donors following informed
onsent was collected by a trained phlebotomist into a 6 ml lavender stopper K2EDTA Vacationer1 tube
BD). All procedures from this point should be performed inside a Class 2 biological safety cabinet:
1 Transfer 6 ml venous blood to a fresh sterile universal tube and add an equal volume of Hank’s
balanced salt solution (HBS); 12 ml total volume.
2 Add 3 ml Ficoll-Paque PLUS to three sterile 15 ml centrifuge tubes and carefully layer 4 ml of the
diluted venous blood on top of the Ficoll-Paque PLUS.
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3 Transfer the tubes to a bench-top centrifuge with swing-out rotor and centrifuge at 400 x g for
40 min at room temperature (1820 C) with the brake off.
4 Carefully remove the tubes from the centrifuge and return to the biological safety cabinet. The
PBMC layer (white and delicate) will be visible at the Ficoll-Paque PLUS interface. Carefully remove
the upper layer (plasma) to waste with a fresh sterile Pasteur pipette without disturbing the PBMC
layer. Then using a fresh sterile Pasteur pipette, transfer the PBMC layer to a fresh 15 ml centrifuge
tube. For each tube, remove the entire PBMC interface with as little of the Ficoll-Paque PLUS layer
as possible.
5 Add 8 ml HBS to each tube and centrifuge at 100–300  g for 10 min at room temperature.
Fig. 1. The effect of exogenous GOX-generated H2O2 on the loss of intracellular reduced thiol using an in vitro
immortalised Jurkat T-cell model. (A) Representative FSC vs SSC ﬂow cytometric proﬁle of GOX treated Jurkat cells (P2). (B)
Histogram (gated on P2) illustrates loss of F5M signal in Jurkat cells following incubation with 5 mU/ml GOX for 0–4 hour (h).
Samples were taken for ﬂow cytometric analysis after the following times; 0 h, 1 h, 2 h, 3 h and 4 h. Data were compared with 0 h
to normalise the loss of F5M signal (see Table 1). (C) Chart illustrates normalised FL1 (laser: l488 nm, ﬁlter: l530/30 nm) MFI.
An increase in F5M signal is noted at 1 h (suggesting a reductive spike), followed by progressive decrease in signal at 2 h–4 h
(suggesting a loss of reduced thiols). Data shown are mean +/ SD of the mean (n = 3). Data analysed by Kruskal–Wallis one-way
analysis of variance with Dunn’s post-hoc test, *p < 0.05, **p < 0.01 and ***p < 0.001.
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16 Using a fresh sterile pipette, remove the supernatant from each tube taking great care not to
disturb the PBMC pellet and suspend in 1 ml HBS. The PBMC’s can be pooled at this stage. Add
sufﬁcient HBS to the pooled cells to make 10 ml.
7 Centrifuge pooled PBMC’s at 100–300  g for 10 min at room temperature.
8 Remove the supernatant taking great care not to disturb the PBMC pellet and suspend the pellet in
2 ml pre-warmed (37 C) complete IMDM. Transfer the cells to an incubator set at 37 C and 5% CO2
for subsequent analysis.
9 Prepare the F5M working solution for ﬂow cytometric use in advance. Protect from light and store
at 4 C (up to 1 month) or at 20 C for up to 1 year.
10 Remove the PBMC’s from the CO2 incubator and centrifuge at 100–300  g in a benchtop
refrigerated centrifuge with swing-out rotor for 5 min at room temperature.
11 Remove supernatant and suspend the pellet in 10 ml D-PBS (equilibrated to room temperature) and
centrifuge at 100–300  g for 10 min.
12 Remove supernatant and suspend the pellet in 1 ml FSB. Prepare a 1 in 20 dilution of the PBMC
suspension for cell viability counting (5 ml PBMC in 95 ml FSB is sufﬁcient) and transfer the
remaining suspension to ice.
able 1
aw ﬂow cytometry data and normalised thiol redox state.
GOX incubation time
(h)
Mean ﬂuorescence intensity (MFI) in FL1
(arbitrary units)
Normalised intracellular thiol redox state (later
time/0 h)#
0 3,163,900.56 0 h MFI/0 h MFI = 1
1 5,409,960.52 1 h MFI/0 h MFI = 1.64 (p < 0.001)
2 1,777,116.26 2 h MFI/0 h MFI = 0.56 (p < 0.01)
3 1,102,371.66 3 h MFI/0 h MFI = 0.34 (p < 0.001)
4 807,302.74 4 h MFI/0 h MFI = 0.25 (p < 0.001)
aw ﬂow cytometric data are normalised to T0 (untreated). #The FL1 MFI is for each time is divided against the FL1 MFI at 0 h.
ata analysed by Kruskal–Wallis one-way analysis of variance with Dunn’s post-hoc test. Values compared with 0 h.
ig. 2. The evaluation of exogenous GOX-derived H2O2 on Jurkat T-cell viability using trypan blue staining. (A) Plot
llustrates the mean Jurkat viability (%) following incubation with 5 mU/ml GOX at 0 h–4 h. To conﬁrm that GOX-derived H2O2
as mediating the loss in reduced intracellular thiol, similar experiments were performed in the presence of 100 mg/ml
atalase. (B) Plot illustrates the normalised mean loss of reduced intracellular thiol at 0 h compared with 4 h (GOX treated) and
 h + C (GOX with catalase treated). Data illustrate that in the presence of catalase, intracellular thiol remains reduced. Data
hown are mean +/ SD of the mean (n = 3). Data analysed by Kruskal–Wallis one-way analysis of variance with Dunn’s post-hoc
est, *p < 0.05, **p < 0.01 and ***p < 0.001.
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13 Mix 10 ml of the 1 in 20 PBMC dilution with 10 ml trypan blue solution and count viable cells using a
haemocytometer.
14 Adjust the PBMC suspension to a density of 107 viable cells/ml with pre-chilled (4 C) FSB and add
100 ml (106 cells) to three fresh 1.5 ml microcentrifuge tubes and centrifuge for 5 min at 100–
300  g and 4 C.
Note: At this point it is preferable to pellet cells using a microcentrifuge.
15 Remove supernatants and suspend each pellet in FSB to a ﬁnal volume of 90 ml.
16 Add 10 ml of mouse anti-human CD3 (clone SK7) APC conjugate to two tubes and 10 ml of mouse
IgG1 APC conjugate isotype control to the other. This step will surface stain the T-cells allowing
intracellular vs extracellular differentiation during confocal microscopy.
17 Vortex all tubes brieﬂy (1 to 2 s) and incubate on ice for 30 min protected from the light.
18 Add 1 ml D-PBS (chilled to 4 C) to each tube and centrifuge for 5 min at 100–300  g and 4 C.
Remove supernatants and then repeat this step.
19 Remove supernatants and add 1 ml D-PBS to the isotype control tube and 1 ml D-PBS to one of the
anti-human CD3 tubes and label it ‘F5M’.
20 Add 1 ml of 1 mM NEM solution to the remaining anti-human CD3 tube. These cells will be used to
set the background for the F5M T-cell stain. Label this tube ‘NEM’.
Note: This concentration of NEM is based on 99+% purity. A lower grade can be used, which may
require titrating to achieve the optimal concentration.
21 Incubate all tubes for 20 min on ice, protected from the light.
22 Centrifuge for 5 min at 100–300  g and 4 C.
23 Remove supernatants and suspend each pellet in 1 ml D-PBS and centrifuge for 5 min at 100–
300  g and 4 C.
24 Remove supernatants and add 1 ml chilled D-PBS to the isotype control tube. These cells will be
used to set the negative T-cell gate. Add 1 ml 0.1 mM F5M to both ‘NEM’ and ‘F5M’ tubes.
25 Incubate all three tubes for 20 min on ice, protected from the light.
26 Centrifuge for 5 min at 100–300  g and 4 C.
27 Remove supernatants and suspend each pellet in 1 ml pre-chilled FSB and centrifuge for 5 min at
100–300  g and 4 C. Repeat this step.
28 Finally remove supernatants and suspend each pellet in 100 ml pre-chilled FSB, keep on ice, protect
from light and go to ﬂow cytometer.
29 At the ﬂow cytometer, acquire the ‘Ig-control’ cells ﬁrst. These cells can be used to set the positive
T-cell gate, which will appear in the FL4 parameter (laser: l640 nm, ﬁlter: l675/25 nm). Fig. 3A
and B illustrates the gating strategy.
30 Next acquire the ‘NEM’ cells and create an FL1 (laser: l488 nm, ﬁlter: l530/30 nm) histogram plot
gated on the T-cell population as seen in Fig. 3B. The peak shown on the FL1 histogram is
representative of the F5M background staining and can be seen in Fig. 3C.
31 Finally acquire the ‘F5M’ cells. As shown in Fig. 3C, these cells ﬂuoresce at an order of magnitude
greater than ‘NEM’ cells.
32 To conﬁrm viability, perform cell counts either before or after ﬂow cytometry acquisition as
described in steps 3 and 4. Fig. 3D shows little loss in cell viability post F5M treatment.
33 As shown in Fig. 3E–G, confocal microscopy is used to conﬁrm that the F5M is entering the T-cells
and therefore that the ﬂow cytometric FL1 signal generated is representative of intracellular thiol
redox status. This supports the notion that the extracellular environment is more ‘oxidising’, thus
cysteine residues here will be to a great extent oxidised i.e. to disulphide or higher oxidation states.
To visualise F5M labelled CD3+ T-cells by confocal microscopy, carefully afﬁx a glass microscope
slide to the microscope and pipette 50–100 ml of the ﬁnal stained cell suspension as a droplet onto
the upper surface. To limit evaporation gently place a thin coverslip (19 mm) on top of the droplet.
Focus cells using a 63 oil immersion objective. Use both the argon (F5M) and helium-neon (CD3-
APC) lasers at a previously determined appropriate power setting, and adjust the offset, gain, zoom
and Z-position as necessary for optimal image quality. If available, opt for sequential scanning
modes to allow simultaneous visualisation of both signals with minimal crosstalk between
channels. DNA stains such as DAPI can be added to the staining protocol to identify nuclear regions
where the appropriate excitation lines and channels are available.
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Fig. 3. Flow cytometric analysis of intracellular thiol redox status in primary human T-cells. PBMC’s were prepared from
venous blood using Ficoll-Paque density centrifugation and washed in D-PBS. Washed PBMC’s (106 cells in 100 ml) were labelled
with anti-human CD3-APC. PBMC’s were then treated with either 1 mM NEM followed by 0.1 mM F5M, or 0.1 mM F5M alone and
analysed by ﬂow cytometry. (A) Representative forward light scatter (FSC) vs side light scatter (SSC) ﬂow cytometric proﬁle with
the treated PBMC’s identiﬁed in P2. (B) Gated on P2, CD3+ T-cells are shown in the FL4 parameter (laser: l640 nm, ﬁlter: l675/
25 nm) in R1 (C). Panel shows representative ﬂuorescence histograms depicting F5M ﬂuorescence in control and treated T-cells
1480 A.J. Wadley et al. / MethodsX 5 (2018) 1473–1483
Analysing F5M labelled proteins extracted from viable cells
The data in the previous section demonstrated that treating viable cells with F5M results in the
labelling of solvent accessible intracellular reduced cysteine thiols [11]. This will include low molecular
weight thiols such as glutathione [12], and solvent accessible cysteine thiols present in the native
conformation of redox active proteins [13]. It would be expected that if a reduced cysteine thiol is
modiﬁed through oxidation, F5M labelling will not occur, since F5M preferentially reacts with reduced
cysteine thiols via the ‘Michael addition’ [14]. Thus identifying individual proteins using proteomic
platforms e.g. mass spectrometry will add greater understanding of how individual cysteine thiols can
modulate biological processes. To demonstrate this principle, proteins from Jurkat cells exposed to
GOX-mediated H2O2 were separated by gel electrophoresis. Untreated vs. F5M SDS-PAGE separated
proteins were then dissected from the gel for analysis by mass spectrometry. This protocol has
potential to be adapted for use with next generation ﬂow cytometers e.g. CyTOF [6,15]. The details of
the experiment used are below:
1 Set up two treatments in 15 ml centrifuge tubes; (i) 2  106 Jurkat cells with 1 mM NEM for 20 min
followed by 20 mM F5M for 20 min, (ii) 2  106 Jurkat cells with F5M only for 20 min. Carry out all
F5M incubations as described in the above sections. Fig. 4A illustrates the level of F5M ﬂuorescence
for these treatments compared to untreated controls as analysed by ﬂow cytometry.
2 Centrifuge the NEM and F5M treated Jurkat cells at 100–300  g for 5 min at 4 C.
3 Remove supernatants and add 10 ml pre-chilled FSB and centrifuge at 100–300  g for 10 min at
4 C.
4 Remove supernatants and suspend both pellets in 400 ml pre-chilled (4 C) PBS and transfer to
fresh microcentrifuge tubes for cell lysis by sonication.
Note: Keep cell lysates on ice and protected from light at all times. This will minimise protein
degradation and protect F5M from photo-bleaching.
5 Centrifuge tubes at 12,000  g for 15 min at 4 C and harvest supernatants into fresh
microcentrifuge tubes on ice and protect from light. Perform protein quantitation on both cell
extracts (Bradford assay [16] or equivalent is appropriate).
6 Add 20 mg of each protein extract to non-reducing NuPAGE1 LDS SDS-PAGE sample loading buffer
made up to a ﬁnal volume of 20 ml and heat at 70 C for 10 min, protected from light. Do not add
reducing agent e.g. 2-mercaptoethanol. Allow samples to cool before loading the Novex1 4–20%
gradient pre-cast tris-glycine gel.
7 Assemble the SDS-PAGE gel tank with the gel and add 1 x NuPAGE1 MOPS SDS-PAGE running
buffer to upper and lower buffer chambers.
8 Load samples along with molecular weight marker and electrophorese at 180 V for 60–80 min, or
until the dye front has run off. It is important to protect the gel and SDS-PAGE gel tank from light
during this procedure.
9 Remove gel to a small tray containing dH2O and scan immediately using a Typhoon-9400
variable mode imager (or equivalent) set at l490–495 nm for excitation and l515–520 nm for
emission.
10 Remove gel from Typhoon directly into SDS-PAGE gel ﬁx solution and incubate for 15 min at room
temperature with gentle agitation.
11 Rinse gel in dH2O and add G-250 colloidal coomassie blue reagent. Incubate overnight (10–20 h) at
room temperature with gentle agitation.
12 Remove G-250 colloidal coomassie blue reagent and de-stain with dH2O for 2 h at room
temperature with gentle agitation. Change the dH2O every 20 min.
13 Scan gel using a standard ﬂatbed SDS-PAGE gel scanner and analyse the data along with the
respective Typhoon ﬂuorescence image data using ImageQuant (v8.1) or equivalent high resolution
software. Fig. 4B shows Typhoon and respective coomassie gel images of proteins extracted from
(gated on R1). (D) T-cell viability was monitored before and after NEM and F5M treatment using trypan blue staining. Confocal
microscopy was used to conﬁrm (E) F5M cellular uptake in PBMCs, (F) surface staining for T-cells with anti-human CD3-APC and
(G) F5M and T-cell overlay.
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1the NEM + F5M treated (i) and F5M alone treated (ii) Jurkat cells. Fig. 4C illustrates pixel peak
proﬁles for NEM + F5M treated (i) and F5M alone treated (ii) extracted proteins.
4 Since F5M irreversible modiﬁes cysteine thiols, identiﬁcation of redox active proteins is permitted
via mass spectrometry based on incremental mass shifts relating to F5M binding. Table 2 shows
ig. 4. Analysis of thiol containing redox active intracellular protein targets following NEM and F5M treatment of viable
urkat T-cells. (A) Panel shows a representative overlaid FL1 (laser: l488 nm, ﬁlter: l530/30 nm) histogram of Jurkat cells
reated with 1 mM NEM + 0.1 mM F5M (i) and 0.1 mM F5M alone (ii). Respective protein extracts were prepared and separated by
DS-PAGE (protected from the light). Fluorescent protein bands were imaged using a Typhoon-9400 variable mode imager set at
490–495 nm for excitation and l515–520 nm for emission. The SDS-PAGE gel was counterstained with G-250 colloidal
oomassie blue to conﬁrm equal gel well loading. (B) Representative gel images for proteins extracted from ﬂow cytometry
L1 peaks (i) and (ii). Typhoon images are presented along with respective Coomassie counterstained images. (C) Representative
ixel peak proﬁles comparing ﬂuorescent protein band intensity between (i) and (ii), lower and upper proﬁles respectively. Five
orresponding gel bands (pixel peaks) are highlighted that differ in ﬂuorescence intensity (no difference was observed for the
espective coomassie counterstain).
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various intracellular redox active proteins identiﬁed from F5M treated Jurkat cells using LC/MS
analysis. For the F5M mass shift, the formula C24H13NO7 (+427.069 Da) was used, since this relates
to the mass difference expected for a Cys-thiol or Cys-thiolate modiﬁcation by F5M.
Note: LC/MS analysis was outsourced to the Bristol Proteomics Facility (University of Bristol, UK).
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Table 2
F5M labelled LC/MS identiﬁed intracellular redox active proteins.
Protein Peptide Sequence Modiﬁed Accession Evidence of Involvement
in Redox Regulation
Ser/Thr protein phosphatase
2A
ENVImSQILPcIK – M5(oxidation) and C11(F5M
addition)
B4DQY1 [17]
N-Methyl-D-aspartate subunit
2D
HcASLELLPPPR – C2(F5M addition) Q59G17 [18]
Human Leukocyte Antigen-
DRB1
LPGGScMAALTVTLMVLSSPLALA – C6(F5M addition) O19734 [19]
Identiﬁcation of key peptides from mass spectrometry analysis (LC/MC) of F5M labelled Cys that were present in Jurkat cells. Gel
slices from proteins extracted from F5M treated cells were prepared following ﬂuorescence SDS-PAGE analysis.
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